Drawing on strong entrepreneurial, medical, technical and leadership backgrounds, Modernizing Medicine’s executive team members are innovators in their fields working together to “modernize medicine” and improve outcomes in healthcare.


Daniel Cane

CEO and co-founder

Daniel is President, CEO and co-founder of Modernizing Medicine. Daniel was named the 2013 Sun Sentinel Excalibur Awards Palm Beach Small Business Leader of the Year, honored as a Palm Beach County Ultimate CEO by the South Florida Business Journal, and as an exceptional leader and innovator with a “40 Under 40” award.

Daniel and Modernizing Medicine co-founder, Chief Medical Officer Michael Sherling, M.D., have grown the company from inception with four rounds of financing, the most recent round occurring in March 2015 with a $20 million investment by Summit Partners, Pentland Group, IBM and previous investors. Since founding the company in 2010, Daniel has led his team to raise a total of over $49 million in funding and to hire approximately 300 employees. Additionally, in December 2014 Daniel led the company through the acquisition of Aesyntix Health, Inc., which enabled Modernizing Medicine to provide revenue cycle management, inventory management and a medical group purchasing organization to its customers. Daniel and Dr. Sherling have also developed an application within EMA, schEMA powered by IBM Watson. The app has been created as part of Modernizing Medicine’s participation in the IBM Watson Ecosystem program designed to help organizations develop a new generation of apps infused with Watson’s cognitive computing intelligence.

Frequently invited to speak at various forums around the State of Florida and across the country, Daniel had the honor in 2013 to participate in The Human Experience, the first TEDxDelrayBeach event. At the United Nations (U.N.) headquarters in New York, he was a panel member at the Economic and Social Council Civil Society Forum: “Building Partnerships in the Field of Education through Science, Technology and Innovation.” He has also spoken at IBM Watson-related events, on South Florida Technology Alliance CEO panels and at other local technology events.

An entrepreneur, Daniel has a BS in Applied Economics from Cornell University, where, as an undergraduate, he co-founded Blackboard Inc., raised over $100 million in venture capital and in 2004 helped take the company public on the NASDAQ (BBBB). In 2011, Blackboard was sold for $1.6 billion.

Active in the local community, Daniel serves as the Vice-Chairman of the Board at the South Florida Science Center and is on the Board of Directors of the United Way of Palm Beach County. Additionally, Governor Rick Scott appointed Daniel to the Florida Atlantic University Board of Trustees for a term beginning August 2013 and ending January 2016; in 2015 he was elected as vice chair. He is an active mentor to entrepreneurs, and a member of the Business Development Board of Palm Beach County, the Boca Chamber of Commerce and several local advisory boards.


Michael Sherling, MD, MBA

Chief Medical Officer

Dr. Michael Sherling is the co-founder and Chief Medical Officer of Modernizing Medicine. He’s responsible for developing and designing the dermatology-based software, and supervising the the design of Modernizing Medicine’s other EMA specialties.

Under his leadership, Modernizing Medicine has gained approximately 30 percent of the US market share in dermatology and raised over $49 million in capital.

Michael has been a practicing dermatologist since 2006. He is currently practicing in a comprehensive skin care dermatology group in Palm Beach County, Florida. He is an expert in medical, surgical and cosmetic dermatology.

Michael is board certified by the American Board of Dermatology. Prior to relocating to Florida, he was the Associate Director of Laser Medicine and Skin Health at Brigham and Women’s Hospital in Boston. He is a leader in resident education, having been the youngest physician to serve as the Associate Residency Program Director for Harvard Medical School’s Department of Dermatology. He has several publications in peer reviewed medical literature.

Michael obtained his B.S. in Biology at Brown University with honors in 1996, his MD from Yale School of Medicine with honors in 2002, and his MBA from Yale School of Management in 2002. He received his clinical training at Harvard Medical School, where he served as chief resident in dermatology. He is licensed to practice medicine in Florida.


Karen O'Byrne

Chief Financial Officer and Chief Operating Officer

Karen serves as Chief Financial Officer and Chief Operating Officer. She oversees all financial, human resources and operations for Modernizing Medicine, and focuses on corporate strategy and planning. Karen brings more than twenty years of financial, accounting and operational experience to Modernizing Medicine. She has broad financial experience in technology-based organizations including enterprise software, B2C technology, systems integration, web hosting and managed services. She is strategically minded with a proven record of driving profit improvement, leading business growth, establishing and scaling operations and building operationally-focused teams.

Prior to Modernizing Medicine, Karen served as the Chief Financial Officer for Campus Management Corp, a software development company that provides post-secondary education institutions with administrative and academic solutions. Karen also served as Senior Director of Business Planning and Finance for Verio, Inc., an NTT America company that provides global web hosting and managed services. Karen began her career in public accounting with nine years of advisory and attestation management experience serving both public and privately-held companies across a wide range of industries.

Karen is a certified public accountant and a certified global management accountant. She holds an MBA with honors and a Bachelor of Science degree in accounting, both from the University of Florida.


Mark Fleisher

Senior Executive Vice President and General Counsel

Mark serves as Senior Executive Vice President and General Counsel. Mark has over fifteen years of experience of providing legal representation to technology companies. Prior to joining Modernizing Medicine, Mark was a partner with K&L Gates LLP, an international law firm.  Prior to K&L Gates, Mark served as Of Counsel with the firm Broad and Cassel and as an associate in the Silicon Valley offices of Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati, P.C. Mark also previously served as Director, Legal—North America for Avanex Corporation, which was a Silicon Valley based provider of photonic processing solutions. Mark received an A.B. degree from Duke University and a J.D. degree from Harvard Law School.